Department of Medicine

(iStock)
February 4, 2026

Clinical trial led by Vanderbilt Health seeks to refine lung cancer biopsy standards

The development of better biopsy approaches is driven by the fact that lung cancer kills more than 130,000 Americans annually, and survival depends on early diagnosis, which requires biopsy to be definitive.

Stokes Peebles, MD, right, Mark Rusznak, PhD, and their colleagues have identified a potential drug target for treating asthma. (photo by Erin O. Smith)
February 4, 2026

Broad genetic study reveals new drug target for asthma

The findings could bring relief to the more than 26 million people in the United States with asthma, a chronic and complex inflammatory disease of the airways.

Clostridium difficile bacterium, 3D illustration
January 28, 2026

Gut microbiome differs according to C. diff symptom status

In a study of children with symptomatic or asymptomatic C. diff, symptom status loomed as the strongest association with differences in gut microbial abundance and diversity.

(iStock)
January 20, 2026

VIGH, Ugandan partners land grant to study bunyaviruses in Tennessee and Uganda

Bunyaviruses can lead to many illnesses, ranging from mild fevers to serious and sometimes deadly diseases such as hemorrhagic fevers and encephalitis in both children and adults.

(iStock)
January 16, 2026

Study finds so-called super agers tend to have at least two key genetic advantages

Super agers were 68% less likely to harbor the gene nobody wants,APOE-ε4, compared to individuals with AD dementia in the same 80+ age group.

(iStock)
January 15, 2026

Immunometabolism may be a key to controlling sepsis: study

This discovery may lead to new ways to block metabolic changes contributing to excessive and ineffective inflammation, reset the immune system, and bring sepsis under control.